drugset / Trial / NCT01628029

Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With Cancer

NCT01628029

RandomizedFactorialDouble-blindSupportive care

Summary

This randomized phase II trial studies how well cognitive behavioral therapy and multimodal therapy works in treating sleep disturbance in patients with cancer. Cognitive behavioral therapy may help reduce sleep disturbances, fatigue, and insomnia as well as improve the well-being and quality of life of patients with cancer when given together with methylphenidate hydrochloride, therapeutic melatonin, and light therapy.

Timeline

Start
2014-01-15
Primary completion
2025-12-22
Completion
2028-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule Oral
Subject Methylphenidate Small molecule Oral